OREANDA-NEWS.   McKesson Corporation (NYSE:MCK), a leading North American healthcare services and information technology company, announced today that McKesson has launched a voluntary public takeover offer (“Takeover Offer”) for the remaining outstanding shares of Celesio AG (“Celesio”) through its indirect wholly-owned subsidiary Dragonfly GmbH & Co. KGaA. There are no closing conditions in relation to the Takeover Offer. McKesson currently exceeds 75% ownership of Celesio shares on a fully diluted basis.

The publication of the offer document for the Takeover Offer has been approved by the Bundesanstalt fьr Finanzdienstleistungsaufsicht and is now available on www.GlobalHealthcareLeader.com in German and in an English translation. Celesio shareholders can now accept the Takeover Offer and tender their shares in Celesio at the offer price of Ђ23.50 per share. The initial acceptance period will end on April 2, 2014 at 24:00 (CET) / 18:00 (EST) and will be followed by an additional two-week acceptance period following the publication of the results of Takeover Offer.